Approximately one‐half of individuals with cancer face personal economic burdens
associated with the disease and its treatment, a problem known as financial toxicity (FT). FT …

Financial toxicity describes the financial burden and distress that can arise for patients, and
their family members, as a result of cancer treatment. It includes direct out-of-pocket costs for …

Abstract In 2021, the American Cancer Society published its first biennial report on the status
of cancer disparities in the United States. In this second report, the authors provide updated …

Atherosclerotic cardiovascular disease (ASCVD) has posed an increasing burden on
Americans and the United States healthcare system for decades. In addition, ASCVD has …

Background Cancer survivors frequently experience medical financial hardship in the United
States. Little is known, however, about long-term health consequences. This study examines …

Background Young adults and other working‐age adults with cancer are at risk for cancer‐
related financial toxicity (FT), including material hardships, depletion of coping resources …

Purpose Financial toxicity has become a global public health issue. The purpose of the
study is to investigate and analyze the influencing factors of financial toxicity in patients with …

Importance In the US, thyroid cancer has been identified as a cancer type with a high degree
of associated financial burden on patients, and survivors of thyroid cancer report higher …

Objective Cancer survival rates have improved over the past few decades, yet
socioeconomic disparities persist. Social determinants of health (SDOH) have consistently …

PURPOSE Although financial toxicity is a growing cancer survivorship issue, no studies
have used credit data to estimate the relative risk of financial hardship in patients with …